N-Acetylcysteine Nanocarriers Protect against Oxidative Stress in a Cellular Model of Parkinson’s Disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
N-Acetylcysteine Nanocarriers Protect against Oxidative Stress in a Cellular Model of Parkinson’s Disease
Authors
Keywords
-
Journal
Antioxidants
Volume 9, Issue 7, Pages 600
Publisher
MDPI AG
Online
2020-07-09
DOI
10.3390/antiox9070600
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dopamine Cytotoxicity on SH-SY5Y Cells: Involvement of α-Synuclein and Relevance in the Neurodegeneration of Sporadic Parkinson’s Disease
- (2019) Upasana Ganguly et al. NEUROTOXICITY RESEARCH
- N‐Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease
- (2019) Daniel A. Monti et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Development of chitosan-coated liposome for pulmonary delivery of N-acetylcysteine
- (2019) Hamed Hamedinasab et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Use of human neuroblastoma SH-SY5Y cells to evaluate glyphosate-induced effects on oxidative stress, neuronal development and cell death signaling pathways
- (2019) María-Aránzazu Martínez et al. ENVIRONMENT INTERNATIONAL
- Deferoxamine and Curcumin Loaded Nanocarriers Protect Against Rotenone-Induced Neurotoxicity
- (2019) Leah Mursaleen et al. Journal of Parkinsons Disease
- Crossing the blood-brain barrier with nanoparticles
- (2018) Yiqun Zhou et al. JOURNAL OF CONTROLLED RELEASE
- Nicotine-Induced Neuroprotection in Rotenone In Vivo and In Vitro Models of Parkinson’s Disease: Evidences for the Involvement of the Labile Iron Pool Level as the Underlying Mechanism
- (2018) Camila Mouhape et al. NEUROTOXICITY RESEARCH
- Therapeutic approaches to target alpha-synuclein pathology
- (2017) Patrik Brundin et al. EXPERIMENTAL NEUROLOGY
- PEG-functionalized zinc oxide nanoparticles induce apoptosis in breast cancer cells through reactive oxygen species-dependent impairment of DNA damage repair enzyme NEIL2
- (2017) Soumyananda Chakraborti et al. FREE RADICAL BIOLOGY AND MEDICINE
- Self-assembled amphiphilic core-shell nanocarriers in line with the modern strategies for brain delivery
- (2017) Reham S. Elezaby et al. JOURNAL OF CONTROLLED RELEASE
- Brain iron concentrations in regions of interest and relation with serum iron levels in Parkinson disease
- (2017) Paola Costa-Mallen et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
- (2017) Helena Xicoy et al. Molecular Neurodegeneration
- N-Acetylcysteine Prevents the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells
- (2017) David S. Goldstein et al. NEUROCHEMICAL RESEARCH
- Iron Mapping in Multiple Sclerosis
- (2017) Stefan Ropele et al. NEUROIMAGING CLINICS OF NORTH AMERICA
- Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
- (2017) Fabio A. Zucca et al. PROGRESS IN NEUROBIOLOGY
- Multifunctional Polymeric Micelles for Combining Chelation and Detection of Iron in Living Cells
- (2017) Zhi Liu et al. Advanced Healthcare Materials
- Investigating the Therapeutic Effects of N-Acetylcysteine Decorated Poly(L-lactic acid) Nanoparticles on Transfusion Induced Acute Lung Injury
- (2017) Qing-Li Dou et al. Journal of Biomaterials and Tissue Engineering
- Restoring the impaired cardiac calcium homeostasis and cardiac function in iron overload rats by the combined deferiprone and N-acetyl cysteine
- (2017) Suwakon Wongjaikam et al. Scientific Reports
- Iron and dopamine: a toxic couple
- (2016) Dominic J. Hare et al. BRAIN
- Effect of PLGA NP size on efficiency to target traumatic brain injury
- (2016) Luis J. Cruz et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases
- (2016) Cláudia Saraiva et al. JOURNAL OF CONTROLLED RELEASE
- Brain Iron Metabolism Dysfunction in Parkinson’s Disease
- (2016) Hong Jiang et al. MOLECULAR NEUROBIOLOGY
- Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC
- (2016) Bruce Do Van et al. NEUROBIOLOGY OF DISEASE
- N-Acetylcysteine in Handgrip Exercise: Plasma Thiols and Adverse Reactions
- (2016) Leonardo F. Ferreira et al. INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM
- N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data
- (2016) Daniel A. Monti et al. PLoS One
- N-acetylcysteine prevents rotenone-induced Parkinson's disease in rat: An investigation into the interaction of parkin and Drp1 proteins
- (2015) Arman Rahimmi et al. BRAIN RESEARCH BULLETIN
- Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis
- (2015) Liuji Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review
- (2015) Deepmala et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid
- (2015) Reno C. Reyes et al. Neurotherapeutics
- Cerebrospinal fluid concentrations of N-acetylcysteine after oral administration in Parkinson's disease
- (2015) Maya Katz et al. PARKINSONISM & RELATED DISORDERS
- Oxidative stress - a key emerging impact factor in health, ageing, lifestyle and aesthetics
- (2015) K. Kandola et al. INTERNATIONAL JOURNAL OF COSMETIC SCIENCE
- Mitochondrial Dysfunction in Parkinson's Disease
- (2015) Hyo Eun Moon et al. Experimental Neurobiology
- Systems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for Parkinson’s disease
- (2015) Abhimanyu Krishna et al. BMC GENOMICS
- Imaging Approach to Mechanistic Study of Nanoparticle Interactions with the Blood–Brain Barrier
- (2014) Mattia Bramini et al. ACS Nano
- The Centrality of Mitochondria in the Pathogenesis and Treatment of Parkinson's Disease
- (2014) Angelique Camilleri et al. CNS Neuroscience & Therapeutics
- Design and Development of Novel Mitochondrial Targeted Nanocarriers, DQAsomes for Curcumin Inhalation
- (2014) Špela Zupančič et al. MOLECULAR PHARMACEUTICS
- Combined Therapy of Iron Chelator and Antioxidant Completely Restores Brain Dysfunction Induced by Iron Toxicity
- (2014) Jirapas Sripetchwandee et al. PLoS One
- N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities
- (2014) Reza Bavarsad Shahripour et al. Brain and Behavior
- Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
- (2013) David Devos et al. ANTIOXIDANTS & REDOX SIGNALING
- High-Dose N-Acetylcysteine in Stable COPD
- (2013) Hoi Nam Tse et al. CHEST
- Bioactive Peptides/Chitosan Nanoparticles Enhance Cellular Antioxidant Activity of (−)-Epigallocatechin-3-gallate
- (2013) Bing Hu et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- The role of mitochondria in aging
- (2013) Ana Bratic et al. JOURNAL OF CLINICAL INVESTIGATION
- Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells
- (2013) Pamela Urrutia et al. JOURNAL OF NEUROCHEMISTRY
- Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor
- (2013) D. T. Wiley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial dysfunctions in Parkinson's disease
- (2013) C.A. Gautier et al. REVUE NEUROLOGIQUE
- Studies on antibacterial activity of ZnO nanoparticles by ROS induced lipid peroxidation
- (2012) R.K. Dutta et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Transferrin-conjugated polyphosphoester hybrid micelle loading paclitaxel for brain-targeting delivery: Synthesis, preparation and in vivo evaluation
- (2012) Pengcheng Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents
- (2012) Sadagopan Magesh et al. MEDICINAL RESEARCH REVIEWS
- The Shape Effect of Mesoporous Silica Nanoparticles on Biodistribution, Clearance, and Biocompatibility in Vivo
- (2011) Xinglu Huang et al. ACS Nano
- Rotenone, Paraquat, and Parkinson’s Disease
- (2011) Caroline M. Tanner et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Leaf extract ofRhus vernicifluaStokes protects dopaminergic neuronal cells in a rotenone model of Parkinson's disease
- (2011) Seung Kim et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Ameliorative Effects of Dimetylthiourea and N-Acetylcysteine on Nanoparticles Induced Cyto-Genotoxicity in Human Lung Cancer Cells-A549
- (2011) Ritesh Kumar Srivastava et al. PLoS One
- Glutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neurons
- (2010) Manuel Garrido et al. ACTA NEUROPATHOLOGICA
- Oxidative Stress in Parkinson's Disease
- (2010) Chun Zhou et al. Annals of the New York Academy of Sciences
- Iron and reactive oxygen species activity in parkinsonian substantia nigra
- (2010) Anna Wypijewska et al. PARKINSONISM & RELATED DISORDERS
- Oral N-Acetyl-Cysteine Attenuates Loss of Dopaminergic Terminals in α-Synuclein Overexpressing Mice
- (2010) Joanne Clark et al. PLoS One
- Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
- (2009) C. H. J. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hydroxyl radical is produced via the Fenton reaction in submitochondrial particles under oxidative stress: implications for diseases associated with iron accumulation
- (2009) Carin Thomas et al. REDOX REPORT
- Mitochondrial mechanisms of estrogen neuroprotection
- (2007) James W. Simpkins et al. BRAIN RESEARCH REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More